Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants

We assessed the immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine (PCV7) administered three, five and 11 months post-natally to 46 pre-term (PT) and 46 full-term (FT) infants. After each dose, there was no significant difference between the groups in antibody leve...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2005-02, Vol.23 (14), p.1703-1708
Hauptverfasser:	Esposito, Susanna, Pugni, Lorenza, Bosis, Samantha, Proto, Alice, Cesati, Laura, Bianchi, Ciro, Cimino, Carolyn, Mosca, Fabio, Principi, Nicola
Format:	Artikel
Sprache:	eng
Schlagworte:	Applied microbiology Bacteriology Biological and medical sciences Disease Enzymes Female Fever - economics Fever - etiology Fever - microbiology Fundamental and applied biological sciences. Psychology Heptavalent Pneumococcal Conjugate Vaccine Humans Immunization Schedule Immunogenicity Infant Infant, Newborn Infant, Premature Infants Male Meningococcal Vaccines - administration & dosage Meningococcal Vaccines - adverse effects Meningococcal Vaccines - economics Microbiology Miscellaneous Pneumococcal conjugate vaccine Pneumococcal Vaccines - administration & dosage Pneumococcal Vaccines - adverse effects Pneumococcal Vaccines - economics Pneumonia Pre-term infants Safety Streptococcus infections Streptococcus pneumoniae Time Factors Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaccines, Conjugate - administration & dosage Vaccines, Conjugate - adverse effects Vaccines, Conjugate - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!